Viewing Study NCT03034733


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-03-05 @ 7:05 PM
Study NCT ID: NCT03034733
Status: TERMINATED
Last Update Posted: 2018-11-29
First Post: 2017-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Dexamethasone on Pain After Total Knee Replacement Surgery
Sponsor: University of Oulu
Organization:

Study Overview

Official Title: The Effect of Intravenous Single-dose Dexamethasone on Pain After Total Knee Replacement Surgery
Status: TERMINATED
Status Verified Date: 2018-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Principal investigator (M.K.) left for another workplace. Patient recruitment more difficult than expected.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to examine, if a single-dose of dexamethasone given during the operation, alleviates pain after knee replacement surgery.
Detailed Description: The purpose of this study is to examine, if a single-dose of dexamethasone given during the operation, alleviates pain after knee replacement surgery. This is also a dose-finding study comparing two doses of dexamethasone.

Total knee arthroplasty causes considerable pain. Multimodal analgesia and peripheral nerve blocks are used for treatment of pain. Some studies suggest that glucocorticoids alleviate postoperative pain. The optimal dose of dexamethasone in treatment of postoperative pain is not known. Studies on this subject in patients with total knee replacement are sparse. Potential side-effects of dexamethasone (hyperglycemia, wound infection) need to be studied.

Patients coming for primary knee replacement surgery are enrolled. The patients in each study group receive multimodal therapy for postoperative pain: etoricoxib, paracetamol, gabapentin and oxycodone. A single dose of intravenous dexamethasone (0,15 mg/kg or 0,25 mg/kg) or a placebo (saline) is administered to the patient during the operation. The effect of dexamethasone on postoperative pain is observed: main outcome is dynamic pain at 24 h postoperatively. The extent of inflammatory reaction is measured (CRP). Serial blood glucose measurements are done.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: